Presented on June 4th, 2021.
Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions.
- Dr. Alla Zosulya-Weidenfeller - Director Medical Affairs, Neurology EMEA
- Dr. Gregory Kaufman – Senior Vice President, Global Clinical and Medical Affairs – Specialty
- Mariska van Aswegen – Vice President, Neurology EMEA